Cargando…
Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
We analyzed samples obtained at baseline and 24 months in a mass azithromycin administration trial in Niger using quantitative polymerase chain reaction. In villages randomized to azithromycin, Shigella was the only pathogen reduced at 24 months (prevalence ratio, 0.36 [95% confidence interval: .17–...
Autores principales: | Platts-Mills, James A, Ayoub, Elias G, Zhang, Jixian, McQuade, Elizabeth T Rogawski, Arzika, Ahmed M, Maliki, Ramatou, Abdou, Amza, Keenan, Jeremy D, Lietman, Thomas M, Liu, Jie, Houpt, Eric R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427139/ https://www.ncbi.nlm.nih.gov/pubmed/35020888 http://dx.doi.org/10.1093/cid/ciab1046 |
Ejemplares similares
-
Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7–11 Years
por: Brennhofer, Stephanie A., et al.
Publicado: (2023) -
Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022) -
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021) -
Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022) -
Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)